Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Asset Writedowns and Impairment (2016)

Updated

Aptevo Therapeutics (APVO) recorded Asset Writedowns and Impairment of $71.01 million in FY2016.

Analysis

Aptevo Therapeutics (APVO) Asset Writedowns and Impairment (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 71.01 Mn
API Access

Aptevo Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=APVO&period=max&api_key=YOUR_API_KEY